Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2013

Keyhani Elahe, Muhammadnejad Ahad, Behjati Farkhondeh, Sirati Fereidoon, Khodadadi Faranak, Karimlou Masoud, Moghaddam Fatemeh A, Pazhoomand Reza

Abstract excerpt

BACKGROUND: Breast cancer is the most common malignancy among women in both developed and developing countries. The burden is increasing in low-income and middle-income countries (LMCs) and threatens the public health of such societies. Introduction of expensive monoclonal antibodies to cancer treatment regimens poses a real challenge in the health systems of LMCs. Despite controversy of cost-effectiveness of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Lobular

Share to Immunoenzyme Techniques

Share to Neoplasm Grading

Share to Neovascularization, Pathologic

Share to Receptor, ErbB-2

Share to Receptors, Progesterone

Source

Identifiers

PMID: 24460348
DOI: 10.7314/apjcp.2013.14.12.7651

Genes

ERBB2
MVD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.PMID 24460348Read ↗

Anti-angiogenesis therapy in cancer: current challenges and future perspectives.Semantic proximity Read ↗

Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal CancerSemantic proximity Read ↗

Angiogenic molecules and mechanisms in breast cancer.Semantic proximity Read ↗

Angiogenesis - still a worthwhile target for breast cancer therapy?Semantic proximity Read ↗

The role of vascular endothelial growth factor a polymorphisms in breast cancer.Semantic proximity Read ↗

Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs.Semantic proximity Read ↗

A new perspective on antiangiogenic antibody drug resistance: Biomarkers, mechanisms, and strategies in malignanciesSemantic proximity Read ↗

Biomarkers of Angiogenesis in Colorectal CancerSemantic proximity Read ↗

The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.Semantic proximity Read ↗

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.Semantic proximity Read ↗

Immunohistochemical evaluation of EGFR protein expression and microvascular density reveals an angiogenic signature in Tunisian patients with metastatic colorectal cancer.Semantic proximity Read ↗

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.